Evropi Theodoratou

Professor of Cancer Epidemiology and Global Health

Biography

Background

Current roles

  • Professor of Cancer Epidemiology and Global Health, University of Edinburgh [2019-]
  • CRUK Career Development Fellow [2017-]
  • Co-lead UNCOVER (Usher Network for COVID-19 Evidence Reviews) [2021-]

Previous roles

  • Reader, University of Edinburgh [2017-2019]
  • Senior Lecturer/ Chancellor’s Fellow, University of Edinburgh [2014-2017]
  • Post-doctoral research fellow, University of Edinburgh [2012-2014]
  • CRUK Population research post-doctoral fellow, University of Edinburgh [2009-2012]

Qualifications

  • BSc in Biology, Aristotle University of Thessalonica, Greece, 2003
  • MSc in Medical Biology, University of Linkoping, Sweden, 2004
  • PhD in Cancer Epidemiology, University of Edinburgh, UK, 2009

Responsibilities & affiliations

  • Fellow by distinction of the Faculty of Public Health (2018)
  • Chief Scientist Office, Health Improvement, Protection and Services Research Committee [2019-]
  • Cancer Research UK, Prevention and Population Research Committee [2020-]
  • Affiliate scientist, Stanford University (USA), Stanford School of Medicine, METRICS (Meta-research Innovation Centre at Stanford) [2018-]

Undergraduate teaching

Programme Director of BMedSci (Epidemiology) intercalated Honours programme that can be taken by medical students in year 3.

Postgraduate teaching

Course Director of “Intermediate Epidemiology”, an elective for the University of Edinburgh’s Master of Public Health (MPH) online programme.

Professor Theodoratou currently supervises MPH students, MSc students, undergraduate students, PhD students (currently 5) and MRes students.

Research summary

Professor Theodoratou’s primary research interest is in colorectal cancer epidemiology (see www.ed.ac.uk/cancer-centre/research/evropi-theodoratou for more information). This research focuses on projects in genetic, molecular and clinical epidemiology. She currently holds six personal awards as PI or co-investigator.

Her CRUK Career Development Fellowship (£1.5m over 6 years) aims to improve and refine bowel cancer identification for those with bowel symptoms, using population screening and diagnostic pathways. The ultimate target is to reduce the overall death rate by improving survival outcomes and patient journeys (see www.ed.ac.uk/usher/lothian-bowel-symptoms-study for more information).

Another active research area is the application of the phenome-wide association study methodology (PheWAS) to investigate the associations between certain genetic variations or biomarker levels and multiple clinical outcomes.

Professor Theodoratou is also interested in developing and applying new research methods in relation to empirical research and evidence-based medicine. She co-leads UNCOVER, a network of population health researchers and information specialists who are committed to responding quickly to requests from policymakers for evidence reviews in relation to the COVID-19 pandemic. See www.ed.ac.uk/usher/uncover for more information.

This article was published on